CellWell record HH-47207
Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials
Ayati Z; Yang G; Ayati MH; Emami SA; Chang D
BMC complementary medicine and therapies ยท 2020
In plain language
A meta-analysis of four randomized trials in people with mild cognitive impairment or Alzheimer's disease found saffron was associated with greater improvement in cognitive test scores than placebo, with no significant change in daily living function.
- Evidence
- Established
- Design
- Meta-analysis
Cite this record: https://thecellwell.org/studies/HH-47207
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.